G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $296,000 | +16.1% | 11,200 | 0.0% | 0.11% | -9.3% |
| Q3 2019 | $255,000 | -94.3% | 11,200 | -92.3% | 0.12% | -92.9% |
| Q2 2019 | $4,472,000 | +174.2% | 146,000 | +48.3% | 1.66% | +175.0% |
| Q1 2019 | $1,631,000 | -43.4% | 98,482 | +36.8% | 0.60% | -56.0% |
| Q3 2018 | $2,884,000 | -7.6% | 72,000 | 0.0% | 1.37% | +14.4% |
| Q2 2018 | $3,121,000 | -18.1% | 72,000 | -30.1% | 1.20% | -19.4% |
| Q1 2018 | $3,813,000 | +393.3% | 103,000 | +164.1% | 1.49% | +444.7% |
| Q4 2017 | $773,000 | -20.4% | 39,000 | 0.0% | 0.27% | -27.8% |
| Q3 2017 | $971,000 | – | 39,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $16,445,000 | 3.96% |
| Burrage Capital Management LLC | 228,597 | $2,640,000 | 2.08% |
| CHI Advisors LLC | 84,000 | $970,000 | 0.34% |
| Birchview Capital, LP | 80,000 | $924,000 | 0.31% |
| Jackson Creek Investment Advisors LLC | 47,294 | $546,000 | 0.25% |
| Rhenman & Partners Asset Management AB | 190,000 | $2,195,000 | 0.20% |
| AIGEN INVESTMENT MANAGEMENT, LP | 90,985 | $1,051,000 | 0.13% |
| Bellevue Group AG | 721,925 | $8,338,000 | 0.12% |
| PDT Partners, LLC | 139,924 | $1,616,000 | 0.11% |
| Virtus ETF Advisers LLC | 16,713 | $193,000 | 0.10% |